| 1 |
32220568 | Increased PUFA levels in kidney epithelial cells in the course of diclofenac toxicity. | 2020 Aug |
1 |
| 2 |
24964408 | Upper limb gangrene following intramuscular diclofenac: a rare side effect. | 2013 Feb 15 |
1 |
| 3 |
19841157 | Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. | 2010 Jan |
3 |
| 4 |
20470236 | Diclofenac: an update on its mechanism of action and safety profile. | 2010 Jul |
1 |
| 5 |
20631416 | Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. | 2010 May-Jun |
1 |
| 6 |
18434566 | Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. | 2008 Jun |
2 |
| 7 |
15705740 | Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. | 2005 Apr |
1 |
| 8 |
12852704 | Valdecoxib: a review. | 2003 Mar |
2 |
| 9 |
10216835 | The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates. | 1999 May |
1 |
| 10 |
10219655 | Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors. | 1999 Mar |
1 |
| 11 |
9444611 | Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. | 1997 Dec |
1 |
| 12 |
7493972 | Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety. | 1995 Dec 8 |
1 |
| 13 |
7965814 | Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. | 1994 Nov |
1 |